Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wysocki

Showing results (331-340 of 335) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 335 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2026
Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA studyP Schmid, H-C Wang, F Lynce, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2014
General parity between trio and pairwise breeding of laboratory mice in static cagingRoss M Kedl, Lawrence J Wysocki, William J Janssen, et al.
Cancers|September 9, 2023
The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER)Paweł Michał Potocki, Rafał Wiśniowski, Dominik Haus, et al.
Physical Review Letters|August 26, 2022
Lawson Criterion for Ignition Exceeded in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.
Physical Review Letters|February 23, 2024
Achievement of Target Gain Larger than Unity in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.
Pageof 34

Showing results (331-340 of 335) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 335 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2026
Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA studyP Schmid, H-C Wang, F Lynce, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2014
General parity between trio and pairwise breeding of laboratory mice in static cagingRoss M Kedl, Lawrence J Wysocki, William J Janssen, et al.
Cancers|September 9, 2023
The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER)Paweł Michał Potocki, Rafał Wiśniowski, Dominik Haus, et al.
Physical Review Letters|August 26, 2022
Lawson Criterion for Ignition Exceeded in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.
Physical Review Letters|February 23, 2024
Achievement of Target Gain Larger than Unity in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.
Pageof 34